share_log

羚锐制药(600285.SH):公司产品拟中选全国中成药采购联盟集中带量采购

Henan Lingrui Pharmaceutical (600285.SH): The company's products are planned to be selected for the national Chinese Patent Medicine procurement alliance's centralized bulk procurement.

Gelonghui Finance ·  Jan 2 04:53

On January 2, Gelonghui reported that Henan Lingrui Pharmaceutical (600285.SH) announced its participation in the tendering work for the national Chinese Patent Medicine procurement alliance's centralized bulk purchasing. According to the proposed selection results for the national Chinese Patent Medicine procurement alliance's centralized bulk purchasing (ZCYLM-2024-1) published by the Hubei Medical Insurance Service Platform on December 30, 2024, the company's product, Qiqi Jiangtang capsules, is slated for selection in this centralized bulk purchasing for Chinese Patent Medicine.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment